Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
NCT ID:
NCT05687032
Group ID:
EG000
Title:
Inotuzumab Ozogamicin (InO)
Description:
Participants received IV infusion of InO as 0.8 mg/m\^2 on Week 1, 0.5 mg/m\^2 on Week2 and 3 every 21-28 days cycle. After Cycle 1: a) participants who achieved desired response, received IV infusion of InO as 0.5 mg/m\^2 on Week 1, Week2 and 3 of subsequent cycles (1 cycle = 28 days); b) participants who did not achieve desired response, received IV infusion of InO as 0.8 mg/m\^2 on Week 1 and 0.5 mg/m\^2 on Week2 and 3 of subsequent cycles (1 cycle = 28 days). Participants who did not achieve desired response within 3 cycles discontinued treatment. Desired response was complete remission or complete remission with incomplete hematologic recovery.
Deaths Number Affected:
17
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
44
Other Number Affected:
44
Other Number At Risk:
44
Study:
NCT05687032
Results Section:
NCT05687032
Adverse Events Module:
NCT05687032